---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-010508"
form_type: "8-K"
ticker: "SENS"
cik: "0001616543"
company_name: "Senseonics Holdings, Inc."
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T19:30:33.201511+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Senseonics Q2 revenue $6.6M (+37% YoY); net loss narrows to $14.5M

## Summary
- Revenue $6.6M, up 37% YoY, driven by 79% U.S. new patient starts growth to $4.9M.
- Net loss $14.5M ($0.02 loss per share) vs $20.3M loss in Q2 2024; gross profit $3.1M vs $0.3M.
- FY2025 revenue guidance reaffirmed at $34-38M; gross margins expected 32.5%-37.5%.
- Raised $77.8M gross proceeds ($57.5M public offering + $20.3M Abbott private placement).
- Entered development agreement with Sequel Med Tech to integrate Eversense 365 with twiist AID system.

## SEC filing metadata
- accession: 0001558370-25-010508
- form_type: 8-K
- ticker: SENS
- cik: 0001616543
- company_name: Senseonics Holdings, Inc.
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1616543/000155837025010508/0001558370-25-010508-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1616543/000155837025010508/sens-20250806x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-010508
- JSON: https://secwatch.observer/filing/0001558370-25-010508.json
- Plain text: https://secwatch.observer/filing/0001558370-25-010508.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.